GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharos IBio Co Ltd (XKRX:388870) » Definitions » Other Long Term Assets

Pharos IBio Co (XKRX:388870) Other Long Term Assets : ₩136.66 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Pharos IBio Co Other Long Term Assets?

Pharos IBio Co's other long-term assets for the quarter that ended in Sep. 2024 was ₩136.66 Mil.

Pharos IBio Co's quarterly other long-term assets increased from Mar. 2024 (₩135.28 Mil) to Jun. 2024 (₩136.59 Mil) and increased from Jun. 2024 (₩136.59 Mil) to Sep. 2024 (₩136.66 Mil).

Pharos IBio Co's annual other long-term assets increased from Dec. 2021 (₩99.59 Mil) to Dec. 2022 (₩262.56 Mil) but then declined from Dec. 2022 (₩262.56 Mil) to Dec. 2023 (₩153.29 Mil).

Pharos IBio Co Other Long Term Assets Historical Data

The historical data trend for Pharos IBio Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharos IBio Co Other Long Term Assets Chart

Pharos IBio Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
201.71 6.92 99.59 262.56 153.29

Pharos IBio Co Quarterly Data
Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.08 153.29 135.28 136.59 136.66

Pharos IBio Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Pharos IBio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharos IBio Co Ltd (XKRX:388870) » Definitions » Other Long Term Assets
Comparable Companies
XKRX:348080 XKRX:065660 XKRX:348150 XKRX:261780 XKRX:365270 XKRX:166480 XKRX:203400 XKRX:234690 XKRX:353810 XKRX:046210 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
427beon-gil, Dongan-gu, 1407 and 1408, 38, Heungan-daero, Seongji Star With, Gyeonggi-do, Gwanyang-dong, Anyang-si, KOR
Website
https://www.pharosibio.com
Pharos IBio Co Ltd is a company specializing in new drug development that develops treatments for rare and intractable diseases. It utilizes a new drug development platform based on big data and AI technology. Its product candidate comprises PHI-101-AML, a treatment drug for refractory/relapsed acute myeloid leukemia; PHI-101-OC developed for platinum-resistant/refractory ovarian cancer patients; PHI-101-TNBC is being developed as a drug to treat metastatic triple-negative breast cancer (TNBC); PHI-201; PHI-301; and PHI-501.

Pharos IBio Co Headlines

No Headlines